Q: What does Syneron do?

A: Syneron Medical Ltd. manufactures and distributes medical aesthetic devices that are powered by its proprietary, patented combined-energy technology of bi-polar Radio Frequency (RF) and optical energy (either laser or light).

Q: What is Syneron’s ticker symbol and on what exchange does it trade?

A: Syneron trades on NASDAQ under the ticker symbol ELOS.

Q: Where and when was Syneron Incorporated?

A: Syneron was incorporated in the state of Israel in July of 2000.

Q: When was Synerons’s initial public offering, and what was the offering price?

A: Syneron’s initial public offering (IPO) was completed August 6, 2004. The company sold a total of 5,500,000 shares in the underwritten offering at $12.00 per share, raising $60 million.

Q: What was the offering price for the secondary offering?

A: Syneron announced a secondary offering on March 9, 2005.  The company sold a total of Syneron 7,000,000 secondary shares held by employees, directors, and founders at $28.00 per share.

Q: Where is Syneron’s headquarters?

A: Syneron’s principal executive offices are located at:
Industrial Zone,
Tavor Building 4,
P.O. Box 550
Yokneam Illit 20692
Israel

Syneron’s primary North American office is located at:
3 Goodyear, Suite A
IRVINE, CA 92618
USA
 
Syneron has offices and distributors throughout the world which provide service and support, including  Asian headquarters in Hong Kong.

Q: When does Syneron’s fiscal year end?

A: Syneron operates on a December 31 fiscal year end.

Q: Who is Syneron’s independent auditor?

A: Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, is Syneron’s auditor.

Q: Who are Syneron’s Officers & Directors?

A: To view a complete list with biographies, click on the Directors and Management links in the Investor Relations section of the Company’s Web site at www.syneron.com.

Q: Who is Syneron’s transfer agent, and how does one contact the transfer agent regarding stock certificates or change of address?

A: The Company’s transfer agent is American Stock Transfer and Trust Company.

American Stock Transfer and Trust Company
59 Maiden Lane
Plaza Level
New York, New York 10038

Toll free: 866-668-6550
Local: 718-921-8346
Fax 718-236-2641
E-Mail: investors@amstock.com
Internet: www.amstock.com

Q: Does Syneron currently pay a dividend on its common stock?

A: Syneron does not currently pay a dividend on its common stock.

Q: Does Syneron offer a direct stock purchase plan?

A: Syneron does not currently offer a direct stock purchase plan.

Q: What is Syneron’s CUSIP number?

A: Syneron’s CUSIP number is M87245102.

Q: How can I contact someone at Syneron with a question or request?

A: Please visit the Investor Relations page on the Company Web site.  A message box is provided in which individual questions can be asked.  

Q: How can I be placed on Syneron’s e-mail news distribution list?

A: To be placed on the Company’s e-mail news distribution list, please visit the Email Alerts link in the Investor Relations section of the Company Web site.

Q: Who are the financial analysts that cover Syneron?

A: A complete list of covering analysts can be found by clicking on the Analysts link.

Q: How can I find information on Syneron’s SEC filings?

A: Syneron files periodic reports with the SEC, including:
· Annual Report on Form 20-F
· Quarterly Reports on Form 6-K, incorporating:
o Quarterly Earnings Results
o Proxy Statement
o Annual Report to Shareholders

These filings can be obtained from the SEC Filings link on the Investor Relations section of the Company Web site or by visiting www.sec.gov.

Q: What are the upcoming events for Syneron?

A: Syneron’s upcoming events can be found by clicking on the Calendar link on the Investor Relations page of the Company’s Web site.